Hawaii Attorney General David Louie filed a lawsuit Wednesday in First Circuit Court to pursue civil penalties over deceptive and unfair marketing practices related to the blood-thinning drug Plavix. The suit alleges the Plavix's manfacturers -- Bristol-Myers Squibb and Sanofi-Aventis -- began deceptively and unfairly labeling and marketing the drug in 1998, but did not disclose that Plavix has a diminished -- or no effect on about 30-percent of the population because they metabolize the drug poorly. Thirty-eight to 79-percent of Pacific Islanders and 40-to-50-percent of East Asians may respond poorly to Plavix. The Attorney General is seeking the maximum civil penalty of $10,000 for each deceptive or unfair act that Plavix's manufacturers committed in relation to the drug's labeling and marketing in Hawaii, as well as an additional civil penalty of $10,000 for each deceptive or unfair act that was directed towards the elderly.
Posted Thursday, March 20th 2014 @ 1pm